Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_assertion description "[Lansoprazole (LPZ), amoxicillin (AMPC) and clarithromycin (CAM) are commonly used drugs (LAC regimen) for Helicobacter pylori (H. pylori) eradication, but the eradication rate with this regimen was reported to be 70% to 90%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_assertion evidence source_evidence_literature NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_assertion SIO_000772 21614934 NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_assertion wasDerivedFrom befree-20140225 NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_assertion wasGeneratedBy ECO_0000203 NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP706548.RAZG3VHJc1IHvCoQHRzp6IarVO-bnf7PBMkwnbtFEsWJs130_provenance.